Monitor McKesson's next quarterly filing for revenue contribution from this VA contract and any updates on the broader medical-surgical spin-off, which may affect the company's government contracting structure.
Price Chart
Executive Summary
McKesson Corporation received a $1.19 billion contract award from the Department of Veterans Affairs as the Pharmaceutical Prime Vendor for July 2026. This is a large, single-agency award that reinforces McKesson's role as a key government pharmaceutical supplier, though the company's annual revenue is not provided in the context for proportional assessment.
Key Financial Metrics
Key Facts
- Award amount: $1,194,619,137.2
- Awarding agency: Department of Veterans Affairs
- Award date: July 1, 2026
- Period of performance starts July 1, 2026
- Description: Pharmaceutical Prime Vendor (PPV) for FY2026 July
- Recipient verified as McKesson Corporation (structural name match: yes)
Financial Impact
$1.19 billion contract award from the VA; revenue impact percentage cannot be calculated as company annual revenue is not provided in the context.
Risk Factors
- Company annual revenue is unknown in the context, preventing proportional impact assessment
- Government contracts may carry funding risk from continuing resolutions or budget changes
- The cross-filing context shows a recent $2.25 billion Term B loan for spin-off costs, indicating significant restructuring that could affect contract execution
Investment Themes
Documents Analyzed
This report is based on 1 federal contract record from official U.S. government contract data.
| Document | Accession Number |
|---|---|
| GOVT-CONTRACT Data (Synthetic) | contract-36C24026K1010 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 12, 2026 15d ago | Institutional Cluster | $955.76 $1,010.43 | ▲ +5.72% | ▲ +7.21% | $969.70 (+1.46%) |
Oct 6, 2026 21d ago | 8-K | $921.67 $961.88 | ▲ +4.36% | ▲ +4.50% | $969.70 (+5.21%) |
Aug 28, 2026 8w ago | 8-K | $885.32 $896.29 | ▲ +1.24% | ▲ +1.38% | $969.70 (+9.53%) |
Aug 1, 2026 12w ago | GOVT-CONTRACT | $827.14 $879.87 | ▲ +6.38% | ▲ +4.35% | $969.70 (+17.24%) |
Jul 1, 2026 16w ago | 8-K | $768.06 $807.33 | ▲ +5.11% | ▲ +4.85% | $969.70 (+26.25%) |
Jul 1, 2026 16w ago | GOVT-CONTRACT | $786.30 $805.96 | ▲ +2.50% | ▲ +1.13% | $969.70 (+23.32%) |
Jun 30, 2026 16w ago | DEFA14A | $768.06 $807.33 | ▲ +5.11% | ▲ +4.85% | $969.70 (+26.25%) |
Jun 12, 2026 19w ago | DEFA14A | $779.78 $744.85 | ▼ −4.48% | ▼ −3.10% | $969.70 (+24.36%) |
Jun 12, 2026 19w ago | 8-K | $784.05 $750.63 | ▼ −4.26% | ▼ −4.94% | $969.70 (+23.68%) |
Jun 8, 2026 20w ago | Insider Cluster | $766.64 $779.78 | ▲ +1.71% | ▼ −0.40% | $969.70 (+26.49%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers